Skip to content
Open access

OpenLipid: a large language model workflow for targeted analysis of DIA mass spectrometry data in lipidomics

Sep 2026 · bioRxiv · 0 citations · 29 references
Biology

TL;DR

OpenLipid is introduced, a large language model (LLM)-based workflow for targeted DIA lipidomics data that directly evaluates extracted ion chromatograms from DIA data in a zero-shot setting to identify target lipid peaks and generate human-readable rationales for individual lipid identification decisions.

Abstract

Mass spectrometry has become a central technology for lipidomics, with data-independent acquisition (DIA) enabling broad and reproducible sampling of lipid signals. However, the multiplexed fragment-ion spectra in DIA data complicate lipid identification. Here, we introduce OpenLipid, a large language model (LLM)-based workflow for targeted DIA lipidomics. Using assay libraries built from data-dependent acquisition (DDA) results, OpenLipid directly evaluates extracted ion chromatograms (XICs) from DIA data in a zero-shot setting to identify target lipid peaks and generate human-readable rationales for individual lipid identification decisions. We benchmarked OpenLipid against manual annotations across four datasets comprising human plasma and mouse feces analyzed in positive and negative ionization modes. The plasma assay libraries contained 199 target lipids in positive mode and 147 in negative mode. The fecal assay libraries contained 181 target lipids in positive mode and 264 in negative mode. At a 5% false discovery rate (FDR) threshold, OpenLipid identified 110 (55.3%) and 28 (19.0%) library targets in plasma and 130 (71.8%) and 84 (31.8%) in feces, in positive and negative ionization modes, respectively. OpenLipid achieved an overall identification rate comparable to that of DIAMetAlyzer (57.8%, 19.7%, 89.0%, and 17.8% across the corresponding datasets) and substantially higher than that of untargeted MS-DIAL DIA analysis (12.6%, 0.0%, 47.5%, and 0.0%) on the same assay-library targets. LLM-derived chromatographic features also enabled supervised discrimination between correct and incorrect candidate peak groups for target lipids, with median cross-validation average precision values of 0.838-0.912. Together, these results demonstrate that OpenLipid is an effective LLM-based workflow for FDR-controlled targeted analysis of DIA lipidomics data.

Read PDF

Similar papers

Open access Sep 2026

Improving lipid identification and quantification: chromatogram deconvolution for LC-MS/MS workflows

Abstract Motivation Lipidomics relies on mass spectrometry-based workflows to identify and quantify complex lipid species. Due to the modular architecture of lipids, including headgroups, backbones, and fatty acyl chains, distinct precursor ions often produce isobaric or identical fragment ions. This problem is amplifi...

Felix Niedermaier, Denise Wolrab-Frühauf, R. Ahrends et al. · 0 citations
Open access Oct 2026

In-silico Tandem Mass Spectral Libraries for the Blood Exposome and Metabolomics Workbench Databases: Application of Gemini Large Language Model

Human body contains endogenous metabolites, nutrients and xenobiotics chemicals. These chemicals can be detected in a biospecimen using high-resolution mass spectrometry instruments, yielding metabolomic and exposomic datasets. Mass spectral libraries are critical components of these workflows to annotate experimental...

Tuan Nguyen, D. Barupal · 0 citations
Open access Oct 2026

Optimizing nanoLC-TIMS-TOF and lipidomics sample preparation for low volume of plasma

The feasibility and practical scalability of positive ion nanoLC-TIMS-MS lipid profiling for sample-limited applications under the evaluated conditions support the feasibility and practical scalability of nanoflow liquid chromatography coupled with trapped ion mobility spectrometry and time-of-flight mass spectrometry.

Klidel Fae B. Rellin, L. Abel, A. Barsch et al. · 1 citation · ⚡1
#protein folding Sep 2026

A Robust DIA-Based Platform for Large-Scale Plasma Glycoproteomics and Biomarker Discovery.

The platform successfully identified glycoform-specific changes and distinguished between noncancer individuals and those with stage III/IV lung cancer, establishing a high-throughput DIA-based glycoproteomics workflow suitable for large-cohort studies to discover glycopeptide biomarker candidates.

Chi-Hung Lin, Sayee Sawale, M. Marispini et al. · 0 citations
2027

Annotating Tandem Mass Spectra in Metabolomics with DreaMS and MassSpecGym.

Overall, this chapter aims to empower biologists and chemists to harness machine learning for metabolomics, transforming unannotated spectra into interpretable chemical knowledge.

Filip Jozefov, Roman Bushuiev, Anton Bushuiev et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.